It was demonstrated that TLR4 contributes to the development of IR and inflammation in obesity via its activation by excess enteric lipopolysaccharide (LPS) and SFAs as well as via endogenous ligands, e.g., FFAs. Here, TLR4 is linked to obesity due to melanocortin 4 receptor deficiency.